化学
部分
抗菌活性
咪唑
立体化学
螯合作用
酶
生物化学
锌
组合化学
细菌
有机化学
生物
遗传学
作者
Yousuke Yamada,Hajime Takashima,Lee Walmsley,Fumihito Ushiyama,Yohei Matsuda,Harumi Kanazawa,Toru Yamaguchi-Sasaki,Nozomi Tanaka-Yamamoto,Junya Yamagishi,Risa Kurimoto-Tsuruta,Yuya Ogata,Norikazu Ohtake,Hayley C. Angove,Lisa M. Baker,Richard Harris,Alba T. Macias,Alan Robertson,Allan E. Surgenor,Hayato Watanabe,Koichiro Nakano
标识
DOI:10.1021/acs.jmedchem.0c01215
摘要
UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) is a zinc metalloenzyme that catalyzes the first committed step in the biosynthesis of Lipid A, an essential component of the cell envelope of Gram-negative bacteria. The most advanced, disclosed LpxC inhibitors showing antibacterial activity coordinate zinc through a hydroxamate moiety with concerns about binding to other metalloenzymes. Here, we describe the discovery, optimization, and efficacy of two series of compounds derived from fragments with differing modes of zinc chelation. A series was evolved from a fragment where a glycine moiety complexes zinc, which achieved low nanomolar potency in an enzyme functional assay but poor antibacterial activity on cell cultures. A second series was based on a fragment that chelated zinc through an imidazole moiety. Structure-guided design led to a 2-(1S-hydroxyethyl)-imidazole derivative exhibiting low nanomolar inhibition of LpxC and a minimum inhibitory concentration (MIC) of 4 μg/mL against Pseudomonas aeruginosa, which is little affected by the presence of albumin.
科研通智能强力驱动
Strongly Powered by AbleSci AI